Impaired insulin receptor signaling is strongly linked to obesity-related metabolic conditions like non-alcoholic fatty liver disease (NAFLD) and Type 2 diabetes (T2DM). This evidence concerns the gene INSR and metabolic dysfunction-associated steatotic liver disease.